Itai Bavli is a PhD Candidate at the University of British Columbia’s Interdisciplinary Studies Graduate Program in the fields of public health, public policy and applied ethics. His research focuses on public health errors and post-market regulations in the United States and Canada. He has recently been awarded the W. Maurice Young Centre for Applied Ethics Graduate Fellowship for a proposal titled: “OxyContin abuse—Ethical issues regarding post-market regulation by the FDA and Health Canada.” He investigates how much evidence – and what kind of evidence – should be sufficient for the Food and Drug Administration (FDA) and Health Canada to justify regulatory action in response to a (potential) public health error.
Mr. Bavli is also a researcher at the Gertner Institute for Epidemiology and Health Policy Research in Israel, where he is part of a research group that investigates the response of health authorities in the United States and Israel to the adverse effects of radiation treatment. He received his BA (Political Science and International Relations) and MA (Political Science) from the Hebrew University of Jerusalem.